Compounds > activins

activins and Weight Loss

activins has been researched along with Weight Loss in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Alexandrou, A; Ghaly, W; Kokkinos, A; Mantzoros, CS; Peradze, N; Perakakis, N; Tentolouris, N; Tsilingiris, D1
Borkowska, A; Malecka-Panas, E; Olakowski, M; Talar-Wojnarowska, R; Wozniak, M1
Bertona, M; Emanuele, E; Fiuza-Luces, C; Lucia, A; Morales, JS; Pareja-Galeano, H; Sanchis-Gomar, F1
Graff, JM; Li, Q; Loveland, KL; Matzuk, MM; O'Connor, AE1
Bradley, A; Coerver, KA; Finegold, MJ; Mather, J; Matzuk, MM; Woodruff, TK1
Davies, MV; Esquela, AF; Haynes, P; Koniaris, LG; Lee, SJ; McPherron, AC; Tomkinson, KN; Wolfman, NM; Zimmers, TA1

Other Studies

6 other study(ies) available for activins and Weight Loss

ArticleYear
Metabolic regulation of activins in healthy individuals and in obese patients undergoing bariatric surgery.
    Diabetes/metabolism research and reviews, 2020, Volume: 36, Issue:5

    Topics: Activins; Bariatric Surgery; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Insulin Resistance; Male; Middle Aged; Obesity, Morbid; Prognosis; Weight Loss

2020
Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2020, Volume: 71, Issue:1

    Topics: Activins; Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Humans; Male; Middle Aged; Myostatin; Pancreatic Neoplasms; Prospective Studies; Weight Loss

2020
Baicalin supplementation reduces serum biomarkers of skeletal muscle wasting and may protect against lean body mass reduction in cancer patients: Results from a pilot open-label study.
    Neuro endocrinology letters, 2016, Volume: 37, Issue:3

    Topics: Absorptiometry, Photon; Activins; Aged; Biomarkers; Body Weight; Cachexia; Endpoint Determination; Female; Flavonoids; Humans; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Neoplasms; NF-kappa B; Pilot Projects; Wasting Syndrome; Weight Loss

2016
SMAD3 regulates gonadal tumorigenesis.
    Molecular endocrinology (Baltimore, Md.), 2007, Volume: 21, Issue:10

    Topics: Activins; Animals; Cell Transformation, Neoplastic; Female; Follicle Stimulating Hormone; Inhibins; Male; Mice; Mice, Knockout; Ovarian Neoplasms; RNA, Messenger; Smad3 Protein; Testicular Neoplasms; Wasting Syndrome; Weight Loss

2007
Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
    Molecular endocrinology (Baltimore, Md.), 1996, Volume: 10, Issue:5

    Topics: Activin Receptors; Activins; Animals; Cachexia; Female; Inhibins; Liver; Male; Mice; Mice, Mutant Strains; Oligopeptides; Ovarian Neoplasms; Peptides; Receptors, Growth Factor; Sex Cord-Gonadal Stromal Tumors; Signal Transduction; Stomach; Testicular Neoplasms; Weight Loss

1996
Induction of cachexia in mice by systemically administered myostatin.
    Science (New York, N.Y.), 2002, May-24, Volume: 296, Issue:5572

    Topics: 3T3 Cells; Activins; Adipose Tissue; Animals; Body Weight; Cachexia; CHO Cells; Cricetinae; Eating; Female; Follistatin; Liver; Mice; Mice, Nude; Muscle Fibers, Skeletal; Muscle, Skeletal; Myostatin; Organ Size; Peptide Fragments; Recombinant Proteins; Transforming Growth Factor beta; Wasting Syndrome; Weight Loss

2002